Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma. Report of a phase I-II study of weekly cisplatin/interferon alfa-2a.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples